Table 3.
Variable | Overall |
---|---|
N = 28 | |
Clinical benefit rate (CR + PR + SD ≥ 24 weeks) n/N (%) | 10/28 (35.7) |
[95% CI] | [18.6–55.9] |
Kaplan-Meier estimate of median duration of clinical benefit (months) | 11.3 |
Disease control rate (CR + PR + SD) n/N | 15/28 (53.6%) |
Kaplan-Meier estimate of median duration of response in disease control (months) | 7.4 |
Kaplan-Meier estimate of median PFS (months) | 4.7 |